Skip to content

Debriefing Consult for Psychiatric Symptoms After Severe Maternal Morbidity

Does a Debriefing Intervention After a Delivery Complicated by Severe Maternal Morbidity Reduce Post-traumatic, Depression, or Anxiety Symptoms? A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07684521
Enrollment
52
Registered
2026-07-06
Start date
2026-07-01
Completion date
2030-07-01
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression - Major Depressive Disorder, PTSD (Childbirth-Related), Severe Maternal Morbidity

Keywords

severe materal morbidity, PTSD, anxiety, depression

Brief summary

The primary objective of this study is to determine if a maternal fetal medicine (MFM) debriefing consult six to eight weeks postpartum reduces self-reported post-traumatic stress, depression, and anxiety symptoms following a delivery complicated by severe maternal morbidity (SMM). Individuals with a delivery complicated an intensive care unit (ICU) admission and/or blood product transfusion \>4 units will be included in this study. Participants will be randomized to an intervention or control group; all participants will complete patient questionnaires that screen for post-traumatic stress disorder, depression, and anxiety. Those in the control group will receive a virtual MFM debriefing consult at six weeks postpartum and those in the intervention group will have the option for a consult at twelve weeks postpartum, after the completion of the questionnaires.

Interventions

BEHAVIORALVirtual maternal fetal medicine debriefing consult

The intervention is virtual debriefing consult with a maternal fetal medicine subspecialist. This intervention involves review of the patient's hospital course and delivery experience, and recommendations for future pregnancies if desired.

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER
Cedars Sinai Medical Center, Los Angeles, USA
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Individuals with a delivery complicated by severe maternal morbidity, defined as intensive care unit (ICU) admission and/or blood product transfusion \>4 units

Exclusion criteria

* Age \<18 years * Non-English speakers * Any records flagged "break the glass" or "research opt out"

Design outcomes

Primary

MeasureTime frameDescription
Depression symptomsFrom 6 to 12 weeks postpartumEdinburgh Postnatal Depression Scale (EPDS) score
PTSD symptomsFrom 6 to 12 weeks postpartumImpact of Event Scale - Revised (IES-R) score
Anxiety symptomsFrom 6 to 12 weeks postpartumGeneralized Anxiety Disorder 7-item (GAD-7) score

Countries

United States

Contacts

CONTACTSarena Hayer, MD, MA, MSc
sarena.hayer@cshs.org323-866-8107
PRINCIPAL_INVESTIGATORSarah Kilpatrick, MD, PhD

Cedars-Sinai Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026